ASPIRE Rheumatology & Inflammatory Bowel Disease Research Awards

Funding Agency:
Pfizer Inc.

This ASPIRE program is part of Pfizer's commitment to supporting research in autoimmune diseases within rheumatology and inflammatory bowel disease.

The mission of the ASPIRE program is to fund high quality basic science, translational and clinical research through a competitive grants program that advances medical knowledge in the epidemiology, pathogenesis and treatment of selected diseases.

Scientific research continues to advance our knowledge and understanding of autoimmune diseases within rheumatology and inflammatory bowel disease. The 2018 ASPIRE Rheumatology and Inflammatory Bowel Disease Research Awards will fund meritorious research proposals that have the potential to improve patient care.

Deadline: January 19, 2018

Agency Website

Eligibility Requirements

This Program is available only to Investigators based in the United States. Both Junior and Senior Investigators are encouraged to apply and consideration will be given to all proposals meeting the selection criteria.

Amount Description

ASPIRE Rheumatology and Dermatology research awards are up to a maximum of $150,000 each.

Funding Type

Grant

Eligibility

Faculty
Junior Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

January 19, 2018